Monograph

The ERS Monograph is the quarterly book series from the ERS.

Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.

Sarcoidosis

European Respiratory Society Monograph, Vol. 32. 2005

ISBN: 978-1-904097-88-4

DOI: 10.1183/1025448x.erm3205

A wide range of acute and chronic pulmonary disorders are capable of diffusely affecting the lung parenchyma with variable amounts of inflammation and fibrosis. A variety of agents and clinical conditions have been associated with interstitial lung disorders. Sarcoidosis is one of the most common causes of idiopathic interstitial lung disease. Clinical presentation can range from asymptomatic to severe respiratory symptoms. Sarcoidosis is considered as a multisystemic disease and chest physicians are frequently involved in the evaluation and management of this disease. The treatment of sarcoidosis ranges from nothing to complex immunosuppressive agents. Given the range of effective therapies for sarcoidosis, appropriate treatment is important. This issue of the European Respiratory Monograph provides the reader with the current status of our understanding of sarcoidosis. Different aspects of the multisystem involvement of this disease condition are discussed by experts in the field of sarcoidosis. Their contributions offer the reader new insights, ideas and perspectives in the management of sarcoidosis.

Preface E.F.M. Wouters Eur Respir Mon; 2005: 32: viii
Introduction M. Drent, U. Costabel Eur Respir Mon; 2005: 32: ix
Definition and history of sarcoidosis O.P. Sharma Eur Respir Mon; 2005: 32: 1–12
Epidemiology of sarcoidosis M. Thomeer, M. Demedts, W. Wuyts Eur Respir Mon; 2005: 32: 13–22
Aetiologies of sarcoidosis L.S. Newman Eur Respir Mon; 2005: 32: 23–48
Immunology and pathophysiology G. Semenzato, M. Bortoli, E. Brunetta, C. Agostini Eur Respir Mon; 2005: 32: 49–63
Genetics R.M. du Bois, P.A. Beirne, S.E. Anevlavis Eur Respir Mon; 2005: 32: 64–81
Pathology V. Poletti, G. Casoni, M. Chilosi Eur Respir Mon; 2005: 32: 82–91
Fatigue, quality of life and health status in sarcoidosis J. De Vries, R.M. Wirnsberger Eur Respir Mon; 2005: 32: 92–104
Pulmonary sarcoidosis J.P. Lynch 3rd, E.S. White Eur Respir Mon; 2005: 32: 105–129
Cardiac involvement in sarcoidosis W. Schulte, D. Kirsten, M. Drent, U. Costabel Eur Respir Mon; 2005: 32: 130–149
Skin manifestations in sarcoidosis A. Eklund, G. Rizzato Eur Respir Mon; 2005: 32: 150–163
Neurosarcoidosis E. Hoitsma, O.P. Sharma Eur Respir Mon; 2005: 32: 164–187
Clinical aspects of ocular sarcoidosis K. Ohara, M.A. Judson, R.P. Baughman Eur Respir Mon; 2005: 32: 188–209
Sarcoidosis: joint, muscle and bone involvement T.L.Th.A. Jansen, P.P.M.M. Geusens Eur Respir Mon; 2005: 32: 210–219
Renal sarcoidosis and hypercalcaemia O.P. Sharma Eur Respir Mon; 2005: 32: 220–232
Rare manifestations of sarcoidosis D.R. Moller Eur Respir Mon; 2005: 32: 233–250
Sarcoidosis in children A. Clement, R. Epaud, B. Fauroux Eur Respir Mon; 2005: 32: 251–258
Diagnostic approach to sarcoidosis U. Costabel, J. Guzman, M. Drent Eur Respir Mon; 2005: 32: 259–264
Sarcoidosis: imaging features J.A. Verschakelen Eur Respir Mon; 2005: 32: 265–283
Clinical usefulness of nuclear imaging techniques in sarcoidosis J. Mañá, M. van Kroonenburgh Eur Respir Mon; 2005: 32: 284–300
Therapy for sarcoidosis R.P. Baughman, E.E. Lower Eur Respir Mon; 2005: 32: 301–315
Rehabilitation programmes in sarcoidosis: a multidisciplinary approach M.A. Spruit, E.F.M. Wouters, R. Gosselink Eur Respir Mon; 2005: 32: 316–326
Transplantation for sarcoidosis I. Saleem, S.O. Beirne, J.J. Egan Eur Respir Mon; 2005: 32: 327–334
History of the WASOG and current activities G. Rizzato Eur Respir Mon; 2005: 32: 335–336
Sarcoidosis patient groups P.Y. Polite Eur Respir Mon; 2005: 32: 337–339
Websites of national and international sarcoidosis patient societies Eur Respir Mon; 2005: 32: 340–341